Chemoinformaics analysis of Ethyl 3-hydroxydecanoate
| Molecular Weight | 216.321 | nRot | 9 |
| Heavy Atom Molecular Weight | 192.129 | nRig | 1 |
| Exact Molecular Weight | 216.173 | nRing | 0 |
| Solubility: LogS | -2.913 | nHRing | 0 |
| Solubility: LogP | 3.308 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 38.449 |
| nHD | 1 | BPOL | 26.681 |
| QED | 0.476 |
| Synth | 2.376 |
| Natural Product Likeliness | 0.92 |
| NR-PPAR-gamma | 0.376 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.38 |
| Pgp-sub | 0.272 |
| HIA | 0.003 |
| CACO-2 | -4.441 |
| MDCK | 0.0000402 |
| BBB | 0.969 |
| PPB | 0.839638 |
| VDSS | 0.695 |
| FU | 0.185367 |
| CYP1A2-inh | 0.861 |
| CYP1A2-sub | 0.648 |
| CYP2c19-inh | 0.577 |
| CYP2c19-sub | 0.481 |
| CYP2c9-inh | 0.445 |
| CYP2c9-sub | 0.654 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.082 |
| CYP3a4-inh | 0.066 |
| CYP3a4-sub | 0.199 |
| CL | 11.27 |
| T12 | 0.781 |
| hERG | 0.042 |
| Ames | 0.011 |
| ROA | 0.014 |
| SkinSen | 0.875 |
| Carcinogencity | 0.185 |
| EI | 0.98 |
| Respiratory | 0.108 |
| NR-Aromatase | 0.018 |
| Antiviral | Yes |
| Prediction | 0.718214 |